8 things you need to know about NICE’s changes to its appraisal process

The National Institute for Health and Care Excellence (NICE) has this week published its updated guide to its health technology appraisal (HTA) process following two rounds of consultations over the last six months. The aim of these changes is to streamline and accelerate the appraisal process. This consultation process has been very low key andRead more

The Health Top Ten: Winter Edition

As the dark mornings set in and we all return to work, WA Health looks at the top ten trends, policy developments and potential pitfalls for the health sector to look out for in the run-up to Spring. New Year, New Me At this time of year many of us give ourselves New Year’s resolutionsRead more

Being led up the garden Pathway: Is there something more to the Accelerated Access Pathway?

The dust has now settled on the Government’s long-long-¬awaited response to the Accelerated Access Review (AAR), which was published on Friday. The key details of the response are relatively well known. The Government is setting up an Accelerated Access Pathway (AAP) to streamline the route to market for around five “breakthrough” treatments every year. TheRead more

NICE approvals – stormy waters

Controversy over which drugs NICE approves and which it doesn’t is rarely out of the news, but of late there has been a particular burst of interest. With healthcare a key election concern, what are the prospects up to and beyond May 2015? Treatment of rare and specialist conditions presents a particular challenge, especially whenRead more